Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 14/20 | 0.50 |
| ▸ | CD274 | Q9NZQ7 | 2/20 | 0.46 |
| ▸ | CNR1 | P21554 | 6/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | BACE1 | P56817 | 1/20 | 0.39 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13162811 | 0.92 | KMT2A (0.48) | CNR2CD274CNR1MAPT | |
| SCHEMBL13634352 | 0.81 | CCR2 (0.39) | CNR2ACHEBACE1 | |
| SCHEMBL2771372 | 0.79 | KMT2A (0.53) | CNR2CD274PDCD1KDM4E | |
| SCHEMBL13634358 | 0.79 | CNR2 (0.47) | CNR2CNR1MAPTKDM4E | |
| SCHEMBL13634497 | 0.73 | KMT2A (0.61) | CNR2KDM4E | |
| SCHEMBL26628833 | 0.73 | MEN1 (0.58) | CNR2CD274CNR1MAPTPDCD1 | |
| SCHEMBL29109429 | 0.73 | MEN1 (0.47) | CNR2CD274CNR1MAPTPDCD1 | |
| SCHEMBL13634354 | 0.73 | CCR2 (0.45) | ACHEBACE1GAA | |
| SCHEMBL4975316 | 0.72 | SMN1; SMN2 (0.52) | CNR2CD274MAPT | |
| SCHEMBL26628831 | 0.72 | TSHR (0.52) | CNR2CD274MAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8304547-B2 | Azolecarboxamide compound or salt thereof | ASTELLAS PHARMA INC. (JP) | 2012-11-06 | — | — | US | disclosed |